Suppr超能文献

深入的天然产物发现——提供多种次生代谢产物的粘细菌菌株。

In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites.

机构信息

Department Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Germany.

Department Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Germany.

出版信息

Biotechnol Adv. 2020 Mar-Apr;39:107480. doi: 10.1016/j.biotechadv.2019.107480. Epub 2019 Nov 7.

Abstract

In recognition of many microorganisms ability to produce a variety of secondary metabolites in parallel, Zeeck and coworkers introduced the term "OSMAC" (one strain many compounds) around the turn of the century. Since then, additional efforts focused on the systematic characterization of a single bacterial species ability to form multiple secondary metabolite scaffolds. With the beginning of the genomic era mainly initiated by a dramatic reduction of sequencing costs, investigations of the genome encoded biosynthetic potential and especially the exploitation of biosynthetic gene clusters of undefined function gained attention. This was seen as a novel means to extend range and diversity of bacterial secondary metabolites. Genome analyses showed that even for well-studied bacterial strains, like the myxobacterium Myxococcus xanthus DK1622, many biosynthetic gene clusters are not yet assigned to their corresponding hypothetical secondary metabolites. In contrast to the results from emerging genome and metabolome mining techniques that show the large untapped biosynthetic potential per strain, many newly isolated bacterial species are still used for the isolation of only one target compound class and successively abandoned in the sense that no follow up studies are published from the same species. This work provides an overview about myxobacterial bacterial strains, from which not just one but multiple different secondary metabolite classes were successfully isolated. The underlying methods used for strain prioritization and natural product discovery such as biological characterization of crude extracts against a panel of pathogens, in-silico prediction of secondary metabolite abundance from genome data and state of the art instrumental analytics required for new natural product scaffold discovery in comparative settings are summarized and classified according to their output. Furthermore, for each approach selected studies performed with actinobacteria are shown to underline especially innovative methods used for natural product discovery.

摘要

在认识到许多微生物能够同时产生多种次生代谢物之后,Zeeck 及其同事在世纪之交引入了“OSMAC”(一种菌株产生多种化合物)这一术语。从那时起,人们又额外致力于系统地研究单一细菌物种形成多种次生代谢物支架的能力。随着基因组时代的开始,主要是由于测序成本的大幅降低,人们开始关注对基因组编码生物合成潜力的研究,特别是对未定义功能的生物合成基因簇的开发。这被视为扩展细菌次生代谢物范围和多样性的一种新方法。基因组分析表明,即使对于研究得很好的细菌菌株,如粘细菌 Myxococcus xanthus DK1622,许多生物合成基因簇仍未被分配到相应的假设次生代谢物。与新兴的基因组和代谢组挖掘技术的结果形成对比,这些技术表明每个菌株都具有巨大的未开发生物合成潜力,但许多新分离的细菌物种仍然只用于分离一类目标化合物,然后被相继放弃,因为没有后续研究再从同一物种发表。这项工作概述了粘细菌菌株,从这些菌株中成功分离出了不止一类而是多类不同的次生代谢物。用于菌株优先级排序和天然产物发现的基础方法,例如针对病原体的混合物进行粗提物的生物学特征分析、从基因组数据中预测次生代谢物丰度的计算方法,以及在比较环境中发现新天然产物支架所需的最先进的仪器分析,都根据其输出进行了总结和分类。此外,对于所选的每个方法,还展示了与放线菌相关的研究,以强调用于天然产物发现的创新方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验